Stoke Therapeutics, Inc. (STOK)
29.03
-1.05
(-3.49%)
USD |
NASDAQ |
May 18, 16:00
29.03
0.00 (0.00%)
After-Hours: 20:00
Stoke Therapeutics Research and Development Expense (Quarterly) : 39.23M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Biogen, Inc. | 471.10M |
| Krystal Biotech, Inc. | 13.81M |
| Scholar Rock Holding Corp. | 51.48M |
| Vertex Pharmaceuticals, Inc. | 961.60M |
| Zymeworks, Inc. | 34.46M |